{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:13:42Z","timestamp":1789298022275,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.aohep.2024.101497","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T08:40:20Z","timestamp":1709800820000},"page":"101497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis"],"prefix":"10.1016","volume":"29","author":[{"given":"Ludmila Resende","family":"Guedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Grossi Lopes","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4606-6454","authenticated-orcid":false,"given":"Bruno Campos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma dos Santos","family":"Jacomassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Jorge","family":"Nardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Maria Farage","family":"Os\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Costa","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Alves","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2024.101497_bib0001","first-page":"113","article-title":"Blutproteine und nahrungseiweiss","volume":"15","author":"Waldenstrom","year":"1950","journal-title":"Blutproteine und Nahrungseiweiss Deutsch Z Verdau Stoffwechselkr"},{"issue":"10","key":"10.1016\/j.aohep.2024.101497_bib0002","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","article-title":"Transitioning from idiopathic to explainable autoimmune hepatitis","volume":"60","author":"Czaja","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2024.101497_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/s0004-28032015000500002","article-title":"Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver","volume":"52","author":"Bittencourt","year":"2015","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101497_bib0004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the liver. EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cld.928","article-title":"Particularities of autoimmune hepatitis in latin america","volume":"16","author":"Terrabuio","year":"2020","journal-title":"Clin Liver Dis (Hoboken) [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology [Internet]"},{"issue":"2","key":"10.1016\/j.aohep.2024.101497_bib0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology [Internet]"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0009","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol [Internet]"},{"issue":"2","key":"10.1016\/j.aohep.2024.101497_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gastrohep.2017.09.003","article-title":"Characterization of patients with autoimmune hepatitis at a university hospital in medell\u00edn-colombia: cohort study","volume":"41","author":"D\u00edaz-Ram\u00edrez","year":"2018","journal-title":"Gastroenterol Hepatol (Engl Ed) [Internet]"},{"key":"10.1016\/j.aohep.2024.101497_bib0011","series-title":"Immunology and liver [Internet]","first-page":"82","article-title":"Autoimmune hepatitis in south America","author":"Can\u00e7ado","year":"2000"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0012","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J Hepatol [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2024.101497_bib0013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2007.12.048","article-title":"Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis","volume":"6","author":"Czaja","year":"2008","journal-title":"Clin Gastroenterol Hepatol [Internet]"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0014","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","article-title":"Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis","volume":"117","author":"Czaja","year":"1999","journal-title":"Gastroenterol [Internet]"},{"issue":"6","key":"10.1016\/j.aohep.2024.101497_bib0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12328-015-0620-9","article-title":"Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis","volume":"8","author":"Umemura","year":"2015","journal-title":"Clin J Gastroenterol [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2024.101497_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","journal-title":"Genes Immun [Internet]"},{"issue":"9","key":"10.1016\/j.aohep.2024.101497_bib0017","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci [Internet]"},{"issue":"12","key":"10.1016\/j.aohep.2024.101497_bib0018","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cgh.2008.08.018","article-title":"Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome","volume":"6","author":"Al-Chalabi","year":"2008","journal-title":"Clin Gastroenterol Hepatol [Internet]"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0019","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology [Internet]"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0020","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology [Internet]"},{"issue":"6","key":"10.1016\/j.aohep.2024.101497_bib0021","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/hep.26290","article-title":"Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study","volume":"57","author":"Ngu","year":"2013","journal-title":"Hepatology [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1665-2681(19)31493-0","article-title":"Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis","volume":"11","author":"Landeira","year":"2012","journal-title":"Ann Hepatol [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2024.101497_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365520903555861","article-title":"Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response","volume":"45","author":"Werner","year":"2010","journal-title":"Scand J Gastroenterol [Internet]"},{"key":"10.1016\/j.aohep.2024.101497_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2018.07.030","article-title":"Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis","volume":"486","author":"Zeng","year":"2018","journal-title":"Clin Chim Acta [Internet]"},{"issue":"3","key":"10.1016\/j.aohep.2024.101497_bib0026","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2024.101497_bib0027","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology [Internet]"},{"issue":"9","key":"10.1016\/j.aohep.2024.101497_bib0028","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.12198","article-title":"Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis","volume":"33","author":"Gutkowski","year":"2013","journal-title":"Liver Int [Internet]"},{"issue":"2","key":"10.1016\/j.aohep.2024.101497_bib0029","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver [Internet]"},{"issue":"12","key":"10.1016\/j.aohep.2024.101497_bib0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/MEG.0000000000000982","article-title":"New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume","volume":"29","author":"Abdel-Razik","year":"2017","journal-title":"Eur J Gastroenterol Hepatol [Internet]"},{"issue":"2","key":"10.1016\/j.aohep.2024.101497_bib0031","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0032","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","author":"Mehendiratta","year":"2009","journal-title":"Clin Gastroenterol Hepatol [Internet]"},{"issue":"6","key":"10.1016\/j.aohep.2024.101497_bib0033","first-page":"e107","article-title":"Incidence and clinical features of autoimmune hepatitis in the province of Santa Fe (Argentina)","volume":"67","author":"Costaguta","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr [Internet]"},{"issue":"7","key":"10.1016\/j.aohep.2024.101497_bib0034","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center","volume":"140","author":"Hoeroldt","year":"2011","journal-title":"Gastroenterology [Internet]"},{"issue":"9","key":"10.1016\/j.aohep.2024.101497_bib0035","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1016\/j.dld.2006.06.021","article-title":"Type 1 autoimmune hepatitis: clinical course and outcome in an Italian multicentre study","volume":"38","author":"Rosa Rizzotto","year":"2006","journal-title":"Dig Liver Dis [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2024.101497_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol [Internet]"},{"issue":"6","key":"10.1016\/j.aohep.2024.101497_bib0037","first-page":"749","article-title":"Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan","volume":"11","author":"Hino","year":"2003","journal-title":"Int J Mol Med [Internet]"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:45:25Z","timestamp":1719531925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1665268124002916"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101497","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101497"}}